• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Live Link
    • Truveta Studio
  • Genomics
  • Solutions
    • Medical devices
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • News
    • Careers

Get started
Sign in
Close

Blog

Truveta is recognized as US and Seattle LinkedIn Top Startup 2024 for innovation and growth in the healthcare industry

Truveta recognized on national and Seattle LinkedIn Top Startup 2024 lists

October 9, 2024
Researchers from Reprieve Cardiovascular use EHR data to study heart failure to understand the need for changes in heart failure treatment decisions and clinical guidelines.

Case study: De-risking clinical development and driving therapeutic innovation in heart failure

September 26, 2024
Using EHR data, Truveta Research monitors hospitalizations associated with the most common respiratory viruses, including influenza, RSV, and COVID. See the latest data through August 2024.

Real-time monitoring of respiratory virus-associated hospitalizations: Trends from October 2019 through August 2024

September 19, 2024
truveta's EHR dataset is the largest mother-child dataset available for linked pairs

Top 10 reasons to choose Truveta’s mother-child EHR dataset

September 13, 2024
Truveta Research uses EHR data to show real-time trends in norovirus and rotavirus.

Real-time monitoring of viral gastroenteritis: August 2024

September 11, 2024
HEOR (health economics and outcomes research) and EHR data UW CHOICE Institute and Truveta partner to advance research

Truveta and the University of Washington’s CHOICE Institute partner to advance health economics and outcomes research

September 4, 2024
Truveta CTO and Co-Founder Jay Nanduri talks about Truveta's approach to making healthcare data available using AI while maintaining privacy and compliance.

Ensuring privacy and compliance of AI

August 30, 2024
Presented at ICPE 2024, Truveta Research explores the time to potassium-lowering drugs after removal of race from CKD-EPI creatinine equation.

ISPE 2024: Exploring the impact of removing race as a diagnostic factor for chronic kidney disease: Time to potassium-lowering drugs

August 23, 2024
  • « Previous
  • 1
  • …
  • 20
  • 21
  • 22
  • …
  • 41
  • Next »

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Research

Resources

Blog

News

Careers

Privacy notice

Contact us

© Truveta 2026

Our website uses cookies to ensure you have the best experience.